YKYann Shan Keh

Yann Shan Keh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yann Shan Keh has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Burden of Valvular Heart Disease Diagnosed on Protocolised Echocardiography for Waitlist Placement in End‐Stage Kidney Patients

    by Quan Yao Ho, Ningyan Wong, Ian Tatt Liew, Carolyn Shan‐Yeu Tien, Yan Nerng Lye, Haoyang Chen, Sharel Zi Hui Ong, Jia Qin Tan, Chin Yee Lee, Sobhana Thangaraju, et al.

    Aim: The burden of valvular heart disease (VHD), which is high amongst end‐stage kidney disease patients (ESKD), is less well defined in those referred to the transplant waitlist. We aimed to determine the prevalence, incidence, impact on survival and risk factors of VHD in ESKD patients who are referred for deceased donor kidney transplant (DDKT). Methods: This is a single‐centre retrospective cohort analysis of ESKD patients who were referred for waitlist placement between 2009 and 2017 and underwent at least 1 transthoracic echocardiogram (TTE), then followed up until death or transplantation. Significant VHD was defined as VHD that was moderate or worse in severity as assessed on echocardiography. Results: Of the 512 patients included, 89 (17.4%) had significant baseline VHD. Over a median follow‐up of 6.6 years, severe VHD (adjusted HR (aHR) 2.73, 95% CI 1.28–5.83, p = 0.009), severe tricuspid regurgitation (aHR 3.04, 95% CI 1.20–7.69, p = 0.02), significant aortic stenosis (aHR 2.93, 95% CI 1.15–7.45, p = 0.02), MS (aHR 3.83, 95% CI 1.54–9.50, p = 0.004) and AR (aHR 1.76, 95% CI 1.05–2.97, p = 0.03) were independently associated with all‐cause mortality. In 350 patients with repeat TTEs, 53 (15.1%) developed de novo significant VHD or progression of pre‐existing VHD, which was independently associated with all‐cause mortality (aHR 2.02, 95% CI 1.14–3.61, p = 0.02). Age, time on dialysis, and mineral bone disease were associated with baseline VHD and de novo or progression of pre‐existing VHD. Conclusion: VHD is common amongst ESKD patients referred for DDKT waitlist. Both baseline and progressive VHD predict worse survival.


  • Open Access

    Real-world Clinical Outcomes in Patients Receiving Zotarolimus-eluting Stents versus Non-zotarolimus-eluting Stents for Percutaneous Coronary Intervention

    by Jonathan Ong Wei Sheng, Muhammad Bin Idu Jion, Keh Yann Shan, Marawan Saber Attia Elkaramany, Gao Fei, Ningyan Wong, Jonathan Jiunn Liang Yap, Chin Chee Yang, Jiang Ming Fam, Kay Woon Ho, et al.

    Background: Current-generation zotarolimus-eluting stents (ZES) have been shown to be an effective choice for percutaneous coronary intervention. However, data comparing real-world clinical outcomes between ZES and other stent platforms (non-ZES) are limited. We aim to compare real-world clinical outcomes of patients receiving ZES versus non-ZES during percutaneous coronary intervention based on our centre’s registry. Methods: This was a non-randomised, non-blinded, all-comers observational registry comparing clinical outcomes in patients treated with ZES versus non-ZES (control). The primary endpoint of our study was defined as major adverse cardiac events, which was a composite of cardiac mortality, target vessel failure and MI at 1 year. Results: Within the study period, 526 patients fulfilled inclusion criteria (ZES: 218, controls: 308). Characteristics and procedural data of both groups were similar. Our study showed no significant differences in major adverse cardiac events between the ZES and control groups (3.2% versus 3.9%; HR 0.82; 95% CI [0.32–2.09]; p=0.68). Comparing clinical outcomes of ZES and control groups, there were similar rates of all-cause mortality (1.4% versus 2.3%; HR 0.60; 95% CI [0.16–2.33]; p=0.46) and MI (0.5% versus 1.0%; HR 0.47; 95% CI [0.049–4.49]; p=0.51). There were low rates of stent-related complications and no differences in target vessel revascularisation (1.4% versus 0.7%; HR 2.12; 95% CI [0.36–12.7]; p=0.41) and target vessel failure (1.4% versus 0.7%; HR 2.12; 95% CI [0.36–12.7]; p=0.41) between the ZES and control groups. Conclusion: Our study showed no significant differences in clinical outcomes between patients receiving ZES and those receiving non-ZES.

  • Open Access

    Cracking the Code of Coronary Calcium: One-year Clinical Outcomes of Intravascular Lithotripsy in All-comers and Two Complex Cohorts

    by Jie Jun Wong, Yann Shan Keh, Yee How Lau, Paul Jie Wen Tern, Abigail Chin Chii Chng, Simon Jung Hyun Kang, Ningyan Wong, Jonathan Jiunn Liang Yap, Thon Hon Yong, Jiang Ming Fam, et al.

    Background: Severe coronary calcifications are commonly encountered in real-world populations and in left main (LM) disease, heightening complication risks including stent underexpansion. Although intravascular lithotripsy (IVL) appears safe, longer-term data in high-risk populations are lacking. The aim of this study was therefore to examine 1-year IVL outcomes for severely calcified lesions in two complex cohorts: LM stenosis and underexpanded stents (UES) during stent implantation. Methods: A registry study was carried out to examine major adverse cardiovascular events (MACEs) (MI, target vessel revascularisation [TVR], cardiac mortality). The LM and UES subgroups were compared with their counterparts in the non-LM and de novo lesion subgroups, respectively. Results: The study involved 102 participants (median age, 70 years, 68% male), and the cardiovascular burden was high (diabetes, 72%; dialysis, 18%; prior MI, 43%, median left ventricular ejection fraction, 45%). Many participants presented acutely (acute coronary syndrome, 36%; decompensated heart failure, 13%) and had complex anatomies (triple-vessel disease, 77%). The cardiovascular burden was higher in the LM and UES subgroups than in the non-LM and de novo lesion subgroups, but the rates of procedural complications and 30-day MACEs were low and were not significantly different. The 1-year MACE rate was higher in the LM group than in non-LM (29% versus 10%, p=0.042), but was non-significant after adjusting for baseline variables (OR 3.08; 95% CI [0.87–10.9]); the rates of 1-year MI, TVR and mortality did not differ from non-LM. In the UES group, 1-year MACE rate (17% versus 13%, p=0.500) was similar to that for de novo lesions. Conclusion: The preliminary data suggest that the use of IVL is reasonable when encountering stent underexpansion due to severe coronary calcifications during stent implantation. The 1-year MACE rate was higher in calcific LM stenosis, probably due to greater comorbidity burden and acute presentations.

  • Open Access

    RotaTripsy Risk and Rewards: Findings from a Registry of Patients Undergoing Combined Rotational Atherectomy and Intravascular Lithotripsy

    by Paul Jie Wen Tern, Yann Shan Keh, Yee How Lau, Jie Jun Wong, Wilbert Hsien Hao Ho, Muhammad Bin Idu Jion, Chee Yang Chin, Benji Lim, Kay Woon Ho, Boon Wah Liew, et al.

    Background: Heavily calcified coronary artery lesions are a therapeutic challenge for interventional cardiologists worldwide. Recently, RotaTripsy has gained popularity as a calcium modification technique prior to stent implantation. In this procedure, operators employ rotational atherectomy to debulk luminal calcium alongside intravascular lithotripsy to fracture deeper concentric calcifications. Aims: To identify the demographics and outcomes of patients undergoing RotaTripsy. Methods: Baseline clinical characteristics, procedural details and in-hospital and 30-day outcomes were recorded and reported for a registry of patients in whom combined rotational atherectomy and intravascular lithotripsy were performed in one procedure at the discretion of the primary operator at one high-volume tertiary centre. Results: Over 2020–2022, 57 consecutive patients underwent RotaTripsy during percutaneous coronary intervention. In this cohort, 23 (40%) had acute coronary syndrome and three (5.3%) had an ST-elevation MI. Additionally, 10 (18%) were on dialysis, 20 (35%) had unprotected left main coronary artery/left main coronary artery equivalent lesions, seven (12%) had acute heart failure and nine (16%) required intraprocedural intra-aortic balloon pump support. Of the procedures, 51 (89.5%) were successful, defined as successful stent implantation and <30% residual angiographic stenosis without in-hospital major adverse cardiac events. Complications included slow/no-reflow (six patients; 11%), cerebrovascular events (three patients; 5.3%), in-hospital MI (three patients; 5.3%) and mortality (three patients; 5.3%). The 30-day MI rate was 5.3% (three patients) and the mortality rate was 7.0% (four patients). Conclusion: RotaTripsy was successful in facilitating stent delivery and restoring flow, even in a relatively sick cohort. Nevertheless, complication rates were high, reflecting the challenge of treating these complex patients.


  • Open Access

    The “cotton candy” clot: organised thrombus adherent to rotational atherectomy burr

    by Yann Shan Keh, Ming Lee, Aaron Sung Lung Wong

  • Open Access

    Cardiac evaluation for end-stage kidney disease patients on the transplant waitlist: a single-center cohort study

    by Swati Vijayan, Quan Yao Ho, Choong Hou Koh, Ian Tatt Liew, Sobhana Thangaraju, Ningyan Wong, Yann Shan Keh, Zi Hui Sharel Ong, Jia Qin Tan, Khung Keong Yeo, et al.

    Swati Vijayan, Quan Yao Ho, Choong Hou Koh, Ian Tatt Liew, Sobhana Thangaraju, Ningyan Wong, Yann Shan Keh, Zi Hui Sharel Ong, Jia Qin Tan, Khung Keong Yeo, Terrance Siang Jin Chua, Terence Kee. Korean J Transplant 2022;36:187-96. https://doi.org/10.4285/kjt.22.0029


  • Open Access

    Coronary Intravascular Lithotripsy Versus Rotational Atherectomy in an Asian Population: Clinical Outcomes in Real-World Patients

    by Jie Jun Wong, Sridharan Umapathy, Yann Shan Keh, Yee How Lau, Jonathan Yap, Muhammad Idu, Chee Yang Chin, Jiang Ming Fam, Boon Wah Liew, Chee Tang Chin, et al.

    Korean Circulation Journal 대한심장학회지 순환기 Wong JJ, et al. Korean Circ J. 2021 Nov;52:e9. https://doi.org/10.4070/kcj.2021.0155


  • OCT and IVUS Appearance of a Neointimal Dissection Within a Recently Implanted Left Main Stent

    by Yann Shan Keh, Chee Yang Chin, Adrian F. Low, Khung Keong Yeo